BMBOY yields 1.54% · JNJ yields 2.13%● Live data
📍 BMBOY pulled ahead of the other in Year 1
Combined, BMBOY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BMBOY + JNJ for your $10,000?
Grupo Bimbo, S.A.B. de C.V., together with its subsidiaries, produces, distributes, and sells various bakery products. The company offers sliced bread, buns and rolls, pastries, cakes, cookies, toast bread, English muffins, bagels, tortillas and flatbreads, salty snacks, and confectionery products. It provides its products under approximately 100 brands. The company operates 206 bakeries and other plants and approximately 1,600 sales centers in 33 countries, including Mexico, the United States, Canada, Latin America, Europe, Asia, and Africa. The company was founded in 1945 and is headquartered in Mexico City, Mexico with additional locations in Argentina, Brazil, Canada, Chile, China, Colombia, Costa Rica, Ecuador, El Salvador, France, Guatemala, Honduras, India, Italy, Kazakhstan, Mexico, Morocco, Nicaragua, Panama, Paraguay, Peru, Portugal, Russia, South Africa, South Korea, Spain, Switzerland, Turkey, Ukraine, the United Kingdom, Uruguay, the United States, and Venezuela.
Full BMBOY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.